Baselga J - Search Results

1

All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas.

Miller WH Jr, Maerz WJ, Kurie J, Moy D, Baselga J, Lucas DA, Grippo JF, Masui H, Dmitrovsky E. Miller WH Jr, et al. Among authors: baselga j. Differentiation. 1994 Jan;55(2):145-52. doi: 10.1046/j.1432-0436.1994.5520145.x. Differentiation. 1994. PMID: 8143931 Free article.

2

Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cell.

Baselga J, Maerz WJ, Moy D, Miller WH Jr, Castro L, Reuter VE, Yao TJ, Masui H, Dmitrovsky E. Baselga J, et al. Oncogene. 1993 Dec;8(12):3257-63. Oncogene. 1993. PMID: 8247529

3

FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.

Maerz WJ, Baselga J, Reuter VE, Mellado B, Myers ML, Bosl GJ, Spinella MJ, Dmitrovsky E. Maerz WJ, et al. Among authors: baselga j. Oncogene. 1998 Aug 13;17(6):761-7. doi: 10.1038/sj.onc.1201992. Oncogene. 1998. PMID: 9715278

4

Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha.

Atlas I, Mendelsohn J, Baselga J, Fair WR, Masui H, Kumar R. Atlas I, et al. Among authors: baselga j. Cancer Res. 1992 Jun 15;52(12):3335-9. Cancer Res. 1992. PMID: 1596891

5

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.

Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E. Rusch V, et al. Among authors: baselga j. Cancer Res. 1993 May 15;53(10 Suppl):2379-85. Cancer Res. 1993. PMID: 7683573

6

Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.

Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller WH Jr, Mendelsohn J. Baselga J, et al. J Natl Cancer Inst. 1993 Aug 18;85(16):1327-33. doi: 10.1093/jnci/85.16.1327. J Natl Cancer Inst. 1993. PMID: 8340945

7

Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.

Fan Z, Baselga J, Masui H, Mendelsohn J. Fan Z, et al. Among authors: baselga j. Cancer Res. 1993 Oct 1;53(19):4637-42. Cancer Res. 1993. PMID: 8402640

8

Autocrine regulation of membrane transforming growth factor-alpha cleavage.

Baselga J, Mendelsohn J, Kim YM, Pandiella A. Baselga J, et al. J Biol Chem. 1996 Feb 9;271(6):3279-84. doi: 10.1074/jbc.271.6.3279. J Biol Chem. 1996. PMID: 8621731 Free article.

9

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth.

Chandarlapaty S, Scaltriti M, Angelini P, Ye Q, Guzman M, Hudis CA, Norton L, Solit DB, Arribas J, Baselga J, Rosen N. Chandarlapaty S, et al. Among authors: baselga j. Oncogene. 2010 Jan 21;29(3):325-34. doi: 10.1038/onc.2009.337. Epub 2009 Oct 26. Oncogene. 2010. PMID: 19855434 Free PMC article.

10

The epidermal growth factor receptor as a target for therapy in breast carcinoma.

Baselga J, Mendelsohn J. Baselga J, et al. Breast Cancer Res Treat. 1994 Jan;29(1):127-38. doi: 10.1007/BF00666188. Breast Cancer Res Treat. 1994. PMID: 8018961 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

585 results

Search Page

Filters